Testing AI text messages to encourage exercise in people with type 2 diabetes
Tests AI text messages to encourage exercise and wellbeing in adults with diabetes.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Developing Resiliency and Exercise Using AI-based Messaging
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- DREAM
- Record updated
- 18 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes who do not get enough physical activity. It tests an 8-week message program to promote physical activity and well-being.
- Age
- Adults (no exact age range is given in the record).
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes (A1c ≥6.5% (48 mmol/mol), fasting glucose ≥126 mg/dL (7 mmol/L)) with low physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item).
- Earlier treatment
- People using non-basal insulin cannot join. People in any other program focused on physical activity or well-being cannot join.
Main reasons for not taking part
- Another condition that limits physical activity
- Taking part in another program on physical activity or well-being
- A cognitive problem that prevents taking part or giving informed consent
- Current pregnancy or plan to become pregnant in the next 16 weeks
- Cannot speak or write fluently in English
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
- Suboptimal physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
- Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser
Who cannot take part
- An unrelated condition limiting physical activity
- Participation in any other programs focused on physical activity or well-being
- A cognitive disturbance precluding participation or informed consent
- Current pregnancy or plan to become pregnant in the next 16 weeks
- Inability to speak/write fluently in English
- Use of non-basal insulin
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Christopher M Celano, M.D.Not yet recruiting
About the trial
What the trial wants to find out
This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.
The 2 groups in the trial
- DREAMTreatment being tested
Participants will engage in twice weekly, interactive messaging sessions with DREAM, a computer-based messaging system designed to help people engage in more physical activity and improve overall well-being. In the first session of each week, participants will set a physical activity goal and learn a new positive psychology topic. They will review goals and topics from the prior week. In the second session, participants will be reminded of the goals set during the first messaging session earlier that week. The program will run for eight weeks.
- Wait-list controlNo study treatment, for comparison
Participants in the wait-list control condition will engage in usual medical care for eight weeks, then will complete the DREAM program.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study
- Plain-language title
- Testing AI text messages to encourage exercise in people with type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 May 2026